Home/Recalls/FDA-D-0785-2026
FDA DrugsClass II

Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Published: September 2, 2026Recall ID: D-0785-2026Category: drugsCountry: US
US
PharmaceuticalFDA DrugsUSUS

Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Recalling Firm: ACCORD HEALTHCARE, INC.

Reason for Recall / Hazard

Subpotent Drug

Product Description & Identification

Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Affected Products

Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Additional Source Details

FieldValue
CityRaleigh
StateNC
Openfda › Upc › 10316729447157
Openfda › Upc › 20316729449151
Openfda › Upc › 30316729452151
Openfda › Upc › 40316729454155
Openfda › Upc › 50316729453158
Openfda › Upc › 60316729448154
Openfda › Upc › 70316729451154
Openfda › Upc › 80316729457156
Openfda › Upc › 90316729450157
Openfda › Upc › 100316729456159
Openfda › Upc › 110316729458153
Openfda › Upc › 120316729455152
Openfda › Unii9J765S329G
Openfda › RouteORAL
Openfda › Rxcui › 1892246
Openfda › Rxcui › 2892251
Openfda › Rxcui › 3892255
Openfda › Rxcui › 4966220
Openfda › Rxcui › 5966221
Openfda › Rxcui › 6966222
Openfda › Rxcui › 7966224
Openfda › Rxcui › 8966225
Openfda › Rxcui › 9966248
Openfda › Rxcui › 10966249
Openfda › Rxcui › 11966253
Openfda › Rxcui › 12966270
Openfda › Spl id415fc774-31a5-124f-e063-6294a90a0e46
Openfda › Brand nameLEVOTHYROXINE SODIUM
Openfda › Spl set ida6233381-3043-4e9a-aaa6-a6b105e5142b
Openfda › Package ndc › 116729-458-15
Openfda › Package ndc › 216729-458-17
Openfda › Package ndc › 316729-447-15
Openfda › Package ndc › 416729-447-17
Openfda › Package ndc › 516729-448-15
Openfda › Package ndc › 616729-448-17
Openfda › Package ndc › 716729-449-15
Openfda › Package ndc › 816729-449-17
Openfda › Package ndc › 916729-451-15
Openfda › Package ndc › 1016729-451-17
Openfda › Package ndc › 1116729-450-15
Openfda › Package ndc › 1216729-450-17
Openfda › Package ndc › 1316729-452-15
Openfda › Package ndc › 1416729-452-17
Openfda › Package ndc › 1516729-453-15
Openfda › Package ndc › 1616729-453-17
Openfda › Package ndc › 1716729-454-15
Openfda › Package ndc › 1816729-454-17
Openfda › Package ndc › 1916729-455-15
Openfda › Package ndc › 2016729-455-17
Openfda › Package ndc › 2116729-456-15
Openfda › Package ndc › 2216729-456-17
Openfda › Package ndc › 2316729-457-15
Openfda › Package ndc › 2416729-457-17
Openfda › Product ndc › 116729-447
Openfda › Product ndc › 216729-458
Openfda › Product ndc › 316729-448
Openfda › Product ndc › 416729-449
Openfda › Product ndc › 516729-451
Openfda › Product ndc › 616729-450
Openfda › Product ndc › 716729-452
Openfda › Product ndc › 816729-453
Openfda › Product ndc › 916729-454
Openfda › Product ndc › 1016729-455
Openfda › Product ndc › 1116729-456
Openfda › Product ndc › 1216729-457
Openfda › Generic nameLEVOTHYROXINE SODIUM
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameLEVOTHYROXINE SODIUM
Openfda › Manufacturer nameAccord Healthcare Inc.
Openfda › Application numberANDA212399
Openfda › Is original packagertrue
Event id99584
Address 18041 Arco Corporate Dr Ste 200
Address 2N/A
Code infoa) Lot # D2402430, D2402431, Exp Date: 10/31/2026. b) Lot #: D2402432, Exp. Date 10/31/2026; D2500180, Exp. Date 12/31/2026.
Postal code27617-2010
Report date20260902
Product typeDrugs
Product quantityN/A
Reason for recallSubpotent Drug
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260806
Initial firm notificationLetter
Center classification date20260821

Check Other Products In Your Household

Free Safety Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Barcode ScannerVIN Vehicle CheckPantry Safety Audit

Overview

  • Recalling FirmACCORD HEALTHCARE, INC.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionNationwide within the United States
Recall Hazard Severity
High Alert (Class I)
Official Agency Alert

📢 Share Warning

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: ACCORD HEALTHCARE, INC. - Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Check if your household is affected:
https://therecallfile.com/recalls/levothyroxine-sodium-tablets-usp-200-mcg-0-2-mg-packaged-in-a-90-count/FDA-D-0785-2026
WhatsAppFacebook

Join Alertlist

Get instant email updates whenever critical safety recalls like this are published.

Featured on Product Hunt

Help support our public safety mission and check out our community launch.

The Recall File - The Google for Product Recalls | Product Hunt

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Donate with PayPal

Supports USD, EUR, GBP, International Cards & PayPal

Spread the WordLevothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Related Recalls

PharmaceuticalUSFDA Drugs

Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228.

Hikma Pharmaceuticals USA INC.
FDA DrugsClass II

Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228.

Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

Sep 2, 2026Hikma Pharmaceuticals USA INC.
PharmaceuticalUSFDA Drugs

Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-448-17.

ACCORD HEALTHCARE, INC.
FDA DrugsClass II

Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-448-17.

Subpotent Drug

Sep 2, 2026ACCORD HEALTHCARE, INC.
PharmaceuticalUSFDA Drugs

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17.

ACCORD HEALTHCARE, INC.
FDA DrugsClass II

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17.

Subpotent Drug

Sep 2, 2026ACCORD HEALTHCARE, INC.

Install The Recall File App

Check safety warnings, scan your pantry, and monitor your vehicles directly from your home screen.